Blog

Home » Blog

ASCO Endorses Localized Prostate Cancer Guideline

A panel of experts at the American Society of Clinical Oncology (ASCO) have reviewed and endorsed Cancer Care Ontario’s guideline on Active Surveillance for the Management of Localized Prostate Cancer. The guidelines, published in May 2015, “are clear, thorough, and based upon the most relevant scientific evidence,” wrote Ronald C. Chen, MD, MPH, associate professor in the department of radiation oncology at UNC-Chapel Hill, and coauthors. Read the article.

ASCO Endorses Localized Prostate Cancer Guideline Read More »

Don’t Take Prostate Cancer Lying Down: 3 Exercises to Work It Out

According to the Seattle Cancer Care Alliance, men who get regular exercise have a slightly lower risk for developing initial prostate cancer. After a prostate cancer diagnosis, patients who maintain a routine of vigorous activity just three hours each week have a much better survival rate. For men who have prostate cancer, working out with these three exercises is especially important. 1. Kegel exercises 2. Weight training 3. Walking Read the article.

Don’t Take Prostate Cancer Lying Down: 3 Exercises to Work It Out Read More »

Video: Justin Lorentz and Dr. Danny Vesprini, “Genetically Predisposed: Who is at Increased Risk of Developing Prostate Cancer?”

March 2016 Awareness Night Genetically Predisposed: Who is at Increased Risk of Developing Prostate Cancer? Justin Lorentz,  MSc, CGC Certified Genetic Counsellor, Male Oncology Research and Education (MORE) Lead, Dept of Radiation Oncology Sunnybrook Odette Cancer Centre   Dr. Danny Vesprini, MD, MSc, FRCPC Assistant Professor, U. of Toronto Dept of Radiation Oncology Affiliate Scientist, Biological Sciences, Sunnybrook Research Institute, Sunnybrook Odette Cancer Centre     CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 85:01 minutes

Video: Justin Lorentz and Dr. Danny Vesprini, “Genetically Predisposed: Who is at Increased Risk of Developing Prostate Cancer?” Read More »

Newsletter April 2016

Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: April 1st – Prostatitis Do It For Dads Walk/Run – Father’s Day 2016 Jan. 2016 Awareness Night – Dr. Shabbir Alibhai discusses Androgen Deprivation Therapy (ADT) in detail Ask the Doctor – Dr. Danny Vesprini:  Does Prostate Cancer ‘Run in the Family’? Board News Bowling Night for our volunteers Revision of PCCN-Toronto governance guidelines The Navigator Project Hospital counselling The 2016 awareness nights schedule Read it by clicking the link below to open the pdf file: March_2016_Newsletter

Newsletter April 2016 Read More »

Circulating Vitamin D and Prostate Cancer Survival

Recent epidemiologic evidence suggests that higher circulating 25-hydroxyvitamin D does not protect against prostate cancer and, in fact, may increase the risk of developing this malignancy. However, few studies have examined the most clinically relevant outcome, prostate cancer mortality. This study showed in a population of men diagnosed with prostate cancer, higher serum 25(OH)D years prior to diagnosis was associated with longer prostate cancer survival. Read the article.

Circulating Vitamin D and Prostate Cancer Survival Read More »

Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy

The association between obesity and aggressive forms of prostate cancer is controversial. A study compared preoperative body mass index (BMI) and prostate-specific antigen (PSA) levels as predictive risk factors for increased prostate weight and disease aggressiveness. Higher BMI was associated with higher prostate weight and PSA, as well as with higher pT stage and pathologic GS in men undergoing radical prostatectomy, providing further evidence that obese men are more likely to have aggressive cancer. BMI thus constitutes an additional risk factor besides PSA. Read the article.

Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy Read More »

New imaging test detects prostate cancer much better than any other tests in use today

Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today. Read the article.

New imaging test detects prostate cancer much better than any other tests in use today Read More »

Scroll to Top